Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

NOF to Invest Big in DDS Materials in Anticipation of Growing Nucleic Acid Drug Market

Filed Under: Pharma Tagged With: , , , , ,

NOF Corp. (TYO:4403) plans to invest more than 10 billion yen ($87.49 million) by fiscal 2025 in its drug delivery…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

NOF Moves to Boost Production of DDS Materials for Biopharmaceuticals
NOF Moves to Boost Production of DDS Materials for…
Mitsui Chemicals to Re-Enter Nucleic Acid Drug CDMO Market
Mitsui Chemicals to Re-Enter Nucleic Acid Drug CDMO Market
Asahi Kasei Advances Into Market for Drug Delivery Systems
Asahi Kasei Advances Into Market for Drug Delivery Systems
Japan Looks to Catch the West as Opportunities Open up for mRNA Pharmaceuticals
Japan Looks to Catch the West as Opportunities Open up for…
Daicel Targets 2024 for Launch of Centralized Medical Business
Daicel Targets 2024 for Launch of Centralized Medical…
KNC Laboratories Eyes Mass Production of Oligonucleotides for Nucleic Acid Drugs
KNC Laboratories Eyes Mass Production of Oligonucleotides…